Podcasts about Garg

Dr. Pedro Barata and Dr. Ravin Garg discuss strategies to increase trial representation, including leveraging trial navigators and prioritizing pragmatic trial models, as featured in the ASCO Educational Book article, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care." TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast from ASCO featuring compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I am a medical oncologist at University Hospital Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I am also the associate editor of the ASCO Educational Book. We know that in recent years, the oncology community has increasingly prioritized the need to modernize clinical trial eligibility, reduce patient burden, and enhance diversity in trial participation. On that note, today we will be speaking about ways to enhance access to clinical trials with Dr. Ravin Garg. He is a hematologist oncologist at Maryland Oncology Hematology and also an assistant professor of oncology at Johns Hopkins Hospital in Baltimore. Dr. Garg is also the co-author of a fantastic paper in the ASCO Educational Book titled, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care."  Dr. Garg, welcome. Thanks for being here, and congrats on your paper. Dr. Ravin Garg: Thank you for having me, Pedro. I am excited to be here. Dr. Pedro Barata: [KI1]  Your paper is a wonderful, multidisciplinary piece that actually features perspectives from the different stakeholders, right? The patient advocacy, industry, community practice, and academia about these challenges in making trials more available. This podcast is a wonderful platform. It reaches out to a lot of folks within our community. So, I will start by asking you the obvious. Why do you think it is a must read for our community, for our listeners? Dr. Ravin Garg: So Pedro, thanks again for inviting me. You do a great job with these podcasts.  So, I think first and foremost, oncologists right now are under a lot of stress, just in terms of clinical volume. There is concern for research money, and how we get the best care for our patients. So I think this article is very important because it helps bring together, as you had mentioned, the stakeholders throughout academic to community practice and everywhere in between, and try to find how, as a team with different oncologists who partake in different aspects of oncology, can come together to streamline the process to try to get our patients on trials, or certainly have them have availability of trials, just if they are interested in going on them. Being in practice, we have had several challenges that we can talk about throughout this podcast, but I think it is a very important paper because it recognizes that at the end of the day, it takes a team effort for all of us in academics, community, industry, and pharmaceuticals to really come together as a team to really help put forth the trials for our patients. Dr. Pedro Barata: So, from the perspective of a community oncologist, how do you put together, or maybe you can describe some of the challenges that you see to increase trial participation in the community? Dr. Ravin Garg: Yes, Pedro, that is a great question, and it is something that I keep on thinking about and trying to find ways to be better at it myself. But I will say some of the challenges as a community doctor that I have seen for myself and talking to other colleagues. Number one, I do think there is a lot of stress on doctors in the community in general, Pedro. Oftentimes we are tasked to see a wide smorgasbord of patients, so we may not have the luxury of being a specialist in any particular tumor subtype. Like oftentimes, we will have to see lung cancer, the next one will be breast cancer, the next one could be CML, the next one could be thrombocytopenia. And as you know better than I do, Pedro, the field in each one of these disciplines is changing so rapidly: molecular genomics, radioligand treatments, different imaging tests, MRD testing for some of our hematologic malignancies. And I think one challenge we have in community is just keeping up with the basics of Oncology 101. In the process of doing that, it can be very difficult to sometimes remember that we have very exciting trials available for our patients. So, I think a lot of it is the day in and day out of being an oncologist is so taxing at times that oftentimes a research trial is not the first thing in our head space when we see a patient. I think number two, Pedro, at least in the community, and perhaps this is with academics too, is that we are bombarded, I would say, by a lot of messaging these days. We have in-baskets to go through, labs to go through, things of that nature. And in the process of a patient visit, seeing them, doing an exam, taking a history, trying to go over the NCCN guidelines on best practice for how to manage their care, at least for me at times, it is very hard to remember, "Hey, there might be a great trial available, whether within our network or maybe partnering with an academic center." So getting through a day can be fraught with a lot of peril and just difficulties, I would say. And I would say number three, Pedro, at least as, you know, I am in a private practice where I do see a wide range of benign and malignant hematology and solid tumors, so I would not call myself a specialist. And I think the challenge with that, at least for trials, Pedro, is that when you are a specialist or perhaps you are focusing on a couple of disease subtypes, you become more of an authoritative voice in those types of tumors, and you might be more aware of the trials within your network or perhaps in proxy with an academic center that you can offer your patient. So I think when sometimes we spread ourselves too thin, it can be very hard to be a thought leader, if you will, in a particular subtype of a malignancy, let's say, and maybe not be aware of a trial that could be really well-suited for your patient. In terms of ideas that myself and colleagues have had in terms of helping mitigate against some of these, I would say, setbacks or issues in the practice for trial enrollment, some of the things we have talked about, Pedro, is, number one, is we do partner with academic centers. So we live here in Maryland. We have several really fantastic academic centers. So, you know, oftentimes, not just within our practice of Maryland Oncology Hematology, we have a lot of great trials available here too, for certain, but in addition to that, we will often times work with doctors at Georgetown, Johns Hopkins, and Maryland if they have a compelling trial that we do not have within our network. It is really of the patient's interest, Pedro, to reach out to them in a collaborative manner to see if they have a trial that might be really compelling for your patient. So I do find myself collaborating a lot with colleagues in, like talented like yourself in academics. You know, I think you do a lot of GU malignancies. So as an example, like partnering with colleagues who are GU experts and say, "Hey, we have a patient with stage IV renal cell. These are the standard options I know, but are there any trials that you might have available?" I think the other thing that has been very helpful for us is having navigators within research, Pedro. Like as an example, what has really helped the uptake of trial enrollment for our center in Annapolis is having a research navigator because often times what they can do is, a priori, Pedro, before you see the patient and you are kind of formulating a standard of care treatment plan perhaps, they might tug you on the shirt and say, "Hey, we have a great trial here through Sarah Cannon, or there might be something else out there." And being aware of that when you go into a patient's room really provides a nice arena, if you will, to go and say, "The standard of care is here, but hey, we have a trial option that might be well suited for you, maybe perhaps even better, that we can talk about, too." So having research support in the community is really a huge boon, I think, Pedro, for us to really increase our enrollment for patients onto trials. Dr. Pedro Barata: Yes, I really love that, Ravin. So, let me switch gears a bit. I would love for you to talk a little bit about patient advocacy because they do play a huge role in cancer, and they address many barriers. How do you think we should leverage the patient advocacy groups to reduce patient burden and maybe have them really leverage patient advocacies to improve representation in clinical trials? What do we think we can do more? Dr. Ravin Garg: Oh, Pedro, I think they are very critically important. As a clinical oncologist now, and I would say this is for anyone in the field of medicine, you are exactly right. I think patients are bombarded by information. There are a lot of things online, whether it be TikTok, Facebook, Google, Yahoo, and people really just have a lot of information given to them. And some of it is fact driven, and some of it is not, Pedro. And oftentimes, I do think there can be at times a mistrust with some medical personnel. I think we are in an era where we are seeing that to some degree with some attributes of medicine. And I think of it as an opportunity for education for the patient and for myself as a physician. And I think patient advocates, to your point, which was well taken, serve as a bridge to both. And what I mean is that, you know, patient advocates are wonderful. They are, I think, outstanding communicators. They almost are a neutral party, Pedro, where many patients feel that they are an independent source of information that is free of bias, if you will. They are there to provide support, emotional support, scientific support for patients so they can make an informed decision. So, in terms of our practice right now, patient advocates is something that we are evolving in that capacity, I would say, Pedro. I think now more than ever, having more people as bridges of communication with care providers along with patients is of critical importance. And I would venture a guess, and I think this has been published, where patient advocates really can help tremendously in familiarizing patients with trials and what they are all about and maybe clear up some misconceptions of what trials, what the mission of trials are. Because I do think some patients, at least I have had a few over the years, where when they hear the term trial, they almost think they are being experimented upon, when, in point of fact, they could really help advance their care. That messaging along the way for some can may be mixed up a little bit. And so I think patient advocates is a really great way to offer more information for patients with a source they find very independent and trustworthy, if you will. And it can really help expedite, and I think make a more fruitful conversation for care providers, whether academic or community, and they might be more open-minded in terms of enrolling onto a trial. Dr. Pedro Barata: Wonderful. Yes, I agree. I agree with you completely.  So let's focus a little bit now on the folks designing the studies. We usually call them the sponsors. It might be an academic sponsorship, if you will, but we can also have pharma being the sponsor of a study. The angle from an academic design, it is not necessarily the same as what happens when we have pharma. And from that angle, how do you think a more inclusive research can be promoted? Dr. Ravin Garg: Oftentimes with trials, I think keeping them simple, as simple as we can. And what I mean by that is, often times for trials, Pedro, even for care providers who are enrolling, it can be daunting when there are a lot of different things involved, particularly, let's say, for investigator sponsored, which are incredibly brilliant science, incredible, but it can be a little bit daunting for patients and even the referring physician to talk about getting translational specimens, imaging, traveling to certain centers to get scans and biopsies and even different diagnostic testing like PSMA testing for, you know, prostate cancer. And it can, I think, be very intimidating for patients in terms of what might be required of him or her to enter onto a trial. Like, "This is not what I signed up for. This is laborious. This is a full time job for me. Do I have to pay for parking to go to a city? Do I have to pay for these imaging tests? And do I have to stay in a place for my family to enroll onto a trial?" So I think keeping trials as simple as possible, but yet cull the data we need as investigators where we can really advance the care, hopefully get approval for a drug, but also learn more about the medication and how it works for our patients. So I think simplifying language for trial is very important. I know when I have gone over studies for patients, Pedro, if it is a voluminous amount of information, they can right away get very intimidated. "Like, oh my goodness, this is like a term paper for college again," you know? I am joking, but you know, keeping language simplified is very important, I think, number one. And I feel that sometimes when they are asked to do a lot of different diagnostic testing, which is very important for translational work, I 100% understand, but I do think sometimes patients can get a little bit off put, if you will, and frustrated with the whole process of doing it. The second thing for our patients, Pedro, that they have mentioned to us when we put them on trials, not just within our own site but elsewhere, is that it takes a lot of time in terms of collecting information, perhaps a washout period from their last standard of treatment prior to enrollment onto a study. Many patients, Pedro, as you know better than I do, are in maybe crisis in terms of their health and their cancer might be growing, promulgating out of control, and they worry about not being able to expeditiously start onto a treatment, onto a trial. So that can lead to a lot of frustration. And one thing that you brought up, which was outstanding for me, is the enrollment criterion for some of our patients is felt to be somewhat strict. We have had some patients who may have had a remote history of a stage I malignancy that was by all accounts in remission, you know, let's say 4 or 5 years in the past, and the risk of recurrence at this point would be incredibly low, but they may not be able to enter onto a study because of some stringent criterion put forth. And that can be a little bit frustrating. In fact, I have had one or two patients who, as an example, with kidney issues, but the GFR was about 60, like right near a cutoff that oftentimes, as you know, we use where you can get into trial or not. And you know, if they are at 58, as an example, and otherwise they are a picture of health, a great candidate for a trial that will likely advance their care, and if the entry criterion is too stringent, that might be a lost opportunity for all parties involved, all stakeholders, if you will. I do appreciate the criterion for entry onto studies cannot be too liberalized. You have to have a certain baseline, but there is a little bit of a gray area and tension, of sorts, if you will, where the patient has a comorbid illness that is a disqualifying offense, but in practicality, perhaps it shouldn't be, especially if they are motivated and there is an opportunity to really advance their care. We have run into, not often, but sometimes in the past, I should say, where patients have been very off put because we try to get them onto a study and there may have been a particular feature or attribute in their underlying care that they couldn't get onto it. So I think having a little bit more thoughtfulness, perhaps, in terms of entry criterion and practicality, if you will, I think would really help enrollment onto studies. Dr. Pedro Barata: Really well said. Is there anything else that you would like to tell our listeners before we wrap up the podcast today? Dr. Ravin Garg: I would say just macroscopically speaking, it is really an honor to be an oncologist. I think I speak for both of us. Anyone listening who is thinking about the field, it is tremendous. Just the research, the bravery of our patients, and the thoughtfulness of our scientists like Pedro and translationalists and clinical trialists is really awe inspiring. So I have really loved this field. I will say from a trial perspective, we really need to enter as many patients as we can onto trials because the science is so brilliant now, the genomic underpinnings of the tumor, we are making great strides as a team of clinicians and scientists, translationalists. So the more that we can get people onto trials and get approved drugs, it is going to help them out in the end. So I think it is such an important time for all of us to come together as a community, find the best way to help our patients out. And clinical trials have to be at the forefront of how we can continue to advance care for our patients. Dr. Pedro Barata: Yeah, no Ravin, I really agree with you. We really need to increase access to clinical studies, and actually your paper is a great step in that direction by raising awareness, bringing up solutions, and again, collaboration, collaboration, collaboration is really a multidisciplinary effort to accomplish that.  Thank you so much for sharing your fantastic thoughts and insights with us. Dr. Ravin Garg: Thank you, Pedro. I am- you do a wonderful job with these podcasts. I am really honored to meet you and to be part of this. Dr. Pedro Barata: And thank you to our listeners for your time today. I encourage you to check out Dr. Garg's article in the 2025 ASCO Educational Book. We will post a link to the paper in our show notes. And please join us again next month on By the Book for more insights on key advances and innovations that are shaping modern oncology. Thank you for your attention. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:          Dr. Pedro Barata   @PBarataMD    Dr. Ravin Garg Follow ASCO on social media:          @ASCO on X      ASCO on Bluesky     ASCO on Facebook       ASCO on LinkedIn       Disclosures:       Dr. Pedro Barata:   Stock and Other Ownership Interests: Luminate Medical   Honoraria: UroToday   Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon   Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas   Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck    Dr. Ravin Garg: Patents, Royalties, Other Intellectual Property: Creator, editor, and writer of hemeoncquestions.com  

From starting a tomato sauce company to launching matchmaking services, Zarna Garg's entrepreneurial spirit has always been on display. But when daughter Zoya Garg dragged her to an open-mic event and introduced her mother to the world of stand-up comedy, the older Garg seemed skeptical. Fast-forward six years later. Now, Zarna Garg has streaming comedy specials, a best-selling book and millions of followers on social media. Host Elahe Izadi spoke with Zarna and Zoya at The Washington Post's Global Women's Summit. Before a live audience, the three explore Zarna's journey to finding comedy, the changing face of the industry on social media, and how it's never too late to launch a second act in life. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

n this conversation, Chanchal Garg shares her journey as an executive coach and author of the intimate and revealing memoire, 'Unearthed: The Lies We Carry and the Truths They Bury.' She discusses her experiences with cultural identity, personal narratives, and the impact of spiritual and sexual abuse on her life. Chanchal emphasizes the importance of owning one's story and the healing process that comes from sharing it. The conversation also touches on the role of spirituality, the influence of guru culture, and the challenges of navigating personal agency within cultural expectations. Ultimately, Chanchal aims to inspire others to question their narratives and find empowerment in their own stories.Chanchal is an Executive Coach and Facilitator of Conscious Leadership who has never been satisfied with “the way things are.” Through all of her professional and personal experiences, Chanchal is committed to going deep--to the layer where we remember life was meant to be so much better than feeling stressed, anxious, and depleted. Chanchal believes that when we invest in revisiting and nourishing our roots, deeper connections revitalize our workplaces and communities.Through her many business roles over the years, including business ownership and facilitating Stanford's interpersonal dynamics graduate business course, she's gained a big picture perspective around strategic thinking, systems evolution, and interpersonal dynamics for relationship-building. Chanchal helps her clients uproot the beliefs and behaviors that keep them small, and begin to cultivate authentic connections with healthy boundaries and expansive vision.  https://www.realspaceco.com/

Comedian Zarna Garg joins Joanna Coles to explore why she avoids political comedy, the pressures of Indian-American family expectations, and the surprising ways the Indian community relates to figures like Trump and Modi. Along with her daughter Zoya, Zarna traces the intersection of heritage, ambition, and representation, from Bollywood-inspired bravado to the delicate balance of supporting daughters marrying across faiths. Along the way, Garg reflects on mentorship, collaboration with Tina Fey and Amy Poehler, and the lessons that have shaped her career. It's a conversation that's at once personal, political, and profoundly revealing—how does heritage shape ambition in America? Hosted on Acast. See acast.com/privacy for more information.

Our chaotic holiday affair is here! Gifts were exchanged, and still, feelings were hurt. Tune in for the gift ideas, stay for the drama. Check out squarespace.com/ZARNA for a free trial, and use OFFER CODE: ZARNA to save 10% off your first purchase of a website or domain. Find gifts so good you'll want to keep them with Quince. Go to Quince.com/ZARNA for free shipping on your order and 365-day returns. #blackfriday #holidays #giftexchange #secretsanta #vlogmas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Shobhit Garg har jobbet med luksusklokker siden han var tenåring, og omsetter nå for 30 millioner kroner i året på å kjøpe og selge dem. I Nettavisen-podkasten «Stavrum & Eikeland», forteller unge Garg hvordan markedet for luksusklokker fungerer og hvorfor det har tatt helt av. See omnystudio.com/listener for privacy information.

From starting a tomato sauce company to launching matchmaking services, Zarna Garg's entrepreneurial spirit has always been on display. But when daughter Zoya Garg dragged her to an open-mic event and introduced her mother to the world of stand-up comedy, the older Garg seemed skeptical.Fast-forward six years later. Now, Zarna Garg has streaming comedy specials, a best-selling book and millions of followers on social media. Host Elahe Izadi spoke with Zarna and Zoya at The Washington Post's Global Women's Summit. Before a live audience, the three explore Zarna's journey to finding comedy, the changing face of the industry on social media, and how it's never too late to launch a second act in life. Subscribe to The Washington Post here.

Amit Garg is the Co-Founder, Managing Partner at Tau Ventures - an AI-first, seed VC fund with $85M+ AUM and focus on automation, digital health, and enterprise with typical check size of $500K. His previous investments include Oak Street Health, Absci, nuTonomy, Misfit Wearables.

Registruokitės į padelio turnyrą gruodžio 12 dieną: https://padeliolyga.lt/turnyrai/pro-x-padel-ii-etapas/registracija   00:00 – Įžanga ir naujas laikas 01:30 – Lietuvos rinktinės stovykla 26:55 – „Lietkabelio“ kova su „Žalgiriu“ 46:20 – „Baskonia“ atvyksta į Kauną 49:35 – „Šiaulių“ pralaimėjimas „Gargždams“ 55:33 – Jonavos sunkumai   #Zalgiris #Rytas #LKL #LietuvosRinktine #Rinktine

#realconversations #Stanford #author #family #marriage#bicultural #facilitator #memoirCONVERSATIONS WITH CALVIN WE THE SPECIES hosted by CalvinSchwartzMeet CHANCHAL GARG “Before our scheduled interview, we setaside a few minutes to get acquainted. Those minutes morphed into sixty. Andthen some. Beyond chemistry. Chanchal's solitary journey from Louisiana, whereshe was a “dutiful Indian daughter,” to being a facilitator at Stanford'sGraduate School of Business (the most popular class, Interpersonal DynamicsLearning) to her deeply personal and hugely brave memoir, ‘Unearthed.' Somewords now from the interview. Spiritual and sexual abuse. Womanhood. Courage.Faith and leaving. Bicultural. Motherhood. Real Space. Authentic Connections.Struggles. Hamilton (the play). Reclaim. For more on these words, check out myinterview with Chanchal Garg.  Curiously, I'm listening to the music theme from Cast Awayas I'm writing this. Ethereal. And so it goes.” Calvinhttps://www.youtube.com/c/ConversationswithCalvinWetheSpecIEs655 Interviews/Videos  9200 SUBSCRIBERSGLOBAL Reach. Earth Life. Amazing People.  PLEASE SUBSCRIBE ** CHANCHAL GARG; Author, ‘Unearthed'(Memoir); Exec Coach(RealSpace); Facilitator, Stanford Univ Graduate School of Business; Speaker; LIVEfrom CaliforniaYouTube:LINKS: linkedin.com/in/chanchalgarg22chanchalgarg.com (Company)realspaceco.com (Company)Unearthed on Amazon:  https://amzn.to/4oidoP1**BIO/ MEMOIRChanchal Garg is a speaker, author, executive coach, andconscious leadership facilitator. She transforms lives by helping clients breakthrough limiting beliefs and build authentic, liberatory connections. Drawingon her MBA and her lived experiences, she addresses difficult truths directlywhile fostering environments of openness and collaboration. For over eightyears, Chanchal has facilitated Stanford University's Graduate School ofBusiness's most popular elective course on interpersonal dynamics, impactingover 500 future business leaders. She is also the founder of Real Space, athriving coaching practice, where she guides leaders to transcend cultural andsocietal constraints, harnessing their personal power in both work and life.Chanchal wrote Unearthed: The Lies We Carry and the Truths They Bury as adeeply personal reclamation-and as an offering. Her voice has been featured atevents like Lululemon's International Women's Day gathering and on podcastssuch as She Has the Mic and The Healing Place.**WE ARE ALSO ON AUDIOAUDIO “Conversations with Calvin; WE the SpecIEs”ANCHOR https://lnkd.in/g4jcUPqSPOTIFY https://lnkd.in/ghuMFeCAPPLE PODCASTSBREAKER https://lnkd.in/g62StzJGOOGLE PODCASTS https://lnkd.in/gpd3XfMPOCKET CASTS https://pca.st/bmjmzaitRADIO PUBLIC https://lnkd.in/gxueFZw  

Lies run through the Garg family…and we're okay with it (expect Zarna). Tune in for the lies we keep from each other, and shockingly, how they've kept our family together.  Check out https://www.squarespace.com/ZARNA for a free trial, and when you're ready to launch, use OFFER CODE: ZARNA to save 10% off your first purchase of a website or domain. Listeners can get a FREE assessment at Mathnasium to start the school year off strong. Go to https://www.MATHNASIUM.COM and find a center near you to redeem your FREE assessment.  Whether you're checking in on a friend or reaching out to a therapist yourself, BetterHelp makes it easier to take that first step. Our listeners get 10% off their first month at https://www.BetterHelp.com/ZARNA.  For the holiday season, Remi is gifting their customers with their “two-in-one foam” that both cleans your night guard and whitens your teeth for FREE when you order a nightguard between now and December 24th. Go to https://www.shopremi.com/ZARNA and use code ZARNA. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Norėdami matyti visą podkastą spauskite čia: https://contribee.com/krepsinisnet 00:00 – prizai jums 03:35 – moterų rinktinės puiki pergalė 09:52 – idėja „Žalgiriui“ ir pralaimėjimas Dubajuje 25:10 – laukianti kelionė į Madridą 30:00 – „Neptūno“ pergalė Utenoje 35:52 – nuviliantis „Ryto“ mačas ir viešnagė Varšuvoje 41:10 – 2,5 valandų mačas Gargžduose 45:35 – gerai kovojusi „Jonava“ 53:27 – „Wolves“ grįš kitą sezoną? Rėmėjų dalyje aptartos šios temos: 1:00:20 – gal neberašykite apie „Jonavą“? 1:08:08 – pastiprinimo ieškanti „Juventus“ 1:13:05 – parduodamas lyderis ir kas vyksta „Nevėžio“ biure? 1:19:43 – „Gargždus“ gali palikti legionierius 1:26:30 – apie „Šiaulių“ naujoką ir C.Reddishą 1:31:20 – A.Rubito alga Malagoje ir kas jį pakeis 1:35:18 – A.Majausko papildymas 1:40:20 – „Rytas“ išnaudojęs visą biudžetą? 1:45:00 – centras „Žalgirio“ sąrašuose ir kodėl negauna šansų J.Rudaitis

असमिया सिंगर और म्यूज़िशियन ज़ुबिन गर्ग की मौत को लेकर जनता के दिल में सिर्फ़ शोक नहीं, क्षोभ भी है. कारण है वो रहस्यमयी हालात जिनमें उनकी मृत्यु हुई और वो Questionable तरीका जिस तरह से उनकी मृत्यु की Investigation की गई. 19 सितंबर 2025 में हुई ज़ुबिन की मौत जहां पहले हादसा लगी, फिर साज़िश और अब इस साज़िश में शामिल हो चुकी हैं कई और परतें. इन्हीं परतों को आज खोलेंगे. समझेंगे कि आखिर Zubeen Garg असम के लिए कौन थे, 19 सितंबर 2025 को सिंगापुर में Exactly हुआ क्या था? क्या कुछ लोग हैं जो इस केस के सॉल्व होने में बाधा बन रहे हैं? वहीं ज़ुबिन जिन्होंने गाया पॉलिटिक्स नोकोरिबा बोन्धू…. उन्हीं की मौत पर राजनीति क्यों हो रही है? इस एपिसोड में हमारे साथ हैं India Today NE को संभालने वाले… साथ ही India Today Magazine के Managing Editor Kaushik Deka.. जिन्होंने न सिर्फ़ अपनी ज़िंदगी के कई साल ज़ुबिन गर्ग के साथ बिताए.. बल्कि वो उन चंद लोगों में से हैं जो ज़ुबिन के जाने के बाद भी लगातार उनके केस पर लिख रहे हैं. प्रड्यूसर: मानव देव रावत साउंड मिक्स: रोहन भारती

100 EPISODES IN!

Norėdami matyti visą podkastą spauskite čia: https://contribee.com/krepsinisnet 00:00 – laimėkite prizus 02:25 – „Barcos“ trenerio pakeitimas 07:35 – puiki „Žalgirio“ pergalė 19:35 – K.Evanso sugrįžimas į Eurolygą 27:42 – žibantis A.Velička ir „Neptūno“ potencialas 35:00 – „Lietkabelio“ pergalė Gargžduose 40:33 – D.Giedraičio sugrįžimas 42:50 – „Ryto“ eksperimentai 47:53 – LKL stebinantys ir nuviliantys 53:33 – už Atlanto Rėmėjų dalyje – pokalbis su Gediminu Navikausku: negirdėtos istorijos, LKL klubų ambicijų trūkumas ir „NBA Europe“ projekto grėsmė

This episode of Fill the Gap features Sunil Garg, CMT, Chief Investment Officer at Lighthouse Canton in Dubai. Sunil discusses the integration of technical and fundamental analysis in global markets, with a particular focus on the current AI-driven bubble and the evolving financial landscape in the UAE and emerging markets. The conversation highlights how price action often leads fundamentals, the importance of humility in forecasting, and the need to adapt analytical tools to different market regimes. He also emphasizes that while bubbles can present opportunities, investors must remain vigilant for signals—such as earnings misses or changes in market breadth—that could indicate a shift in market conditions.Fill the Gap, hosted by David Lundgren, CMT, CFA and Tyler Wood, CMT brings veteran market analysts and money managers onto a monthly podcast. For complete show notes of every episode, visit: https://cmtassociation.org/development/podcasts/ Give us a shout:@dlundgren3333 or https://www.linkedin.com/in/david-lundgren-cmt-cfa-63b73b/@_TBone_Pickens or https://www.linkedin.com/in/tyler-wood-cmt-b8b0902/@CMTAssociation orhttps://www.linkedin.com/company/cmtassociationCMT Association is the global credentialing authority committed to advancing the discipline of technical analysis in the financial services industry. We serve members in over 137 countries. Our mission is to elevate investors mastery and skill in mitigating market risk and maximizing return in capital markets through a rigorous credentialing process, professional ethics, and continuous education. CMT Association formed in the late 1960s with headquarters in lower Manhattan, NY and Mumbai, India.Learn more at: www.cmtassociation.org

Norėdami matyti visą podkastą spauskite čia: https://contribee.com/krepsinisnet 00:00 – įžanga 03:40 – „Juventus“ pergalė 15:23 – A.Gudaitis grįš į Eurolygą? 24:33 – du E.Ulanovai ir treniruotė Gargžduose 30:57 – 230 taškų mačas Klaipėdoje 36:23 – svarstys E.Skersį 40:00 – „Žalgirio“ du varžovai 47:02 – Europos taurės reikalai 51:47 – NBA lietuvių savaitė 57:23 – papildymai Eurolygoje Rėmėjų dalyje kalbėta apie lažybas krepšinyje: 1:03:23 – M.Janišius: apie lažybas, jų organizavimą ir sistemos spragas

00:00 – Įžanga 02:50 – Gosso trauma 08:20 – Maodo Lo nežaidė Gargžduose 15:30 – Žalgiris pasitinka Virtus 18:35 – ASVEL lyderiai 22:05 – „Žalgiris“ vs „Rytas“ 27:00 – „Rytas“ ir Gudaičio forma 33:45 – Cam Reddish motyvacija 35:40 – Lietkabelio kalneliai 40:00 – Budočnost ir Cedevita 44:00 – Karštas Masiulio komentaras 45:33 – Neptūno ir Jonavos NBA

क्रिकेट के पुराने दीवाने आज भी विनीत गर्ग की आवाज़ और उनकी कॉमेंट्री के अंदाज़ पर जान छिड़कते हैं. विनीत जी आकाशवाणी के ज़रिये कई दशकों से क्रिकेट के खेल का आंखोंदेखा हाल सुनाते आए हैं. कुछ तो बात है उनकी कॉमेंट्री में कि एकबार कानों में पड़ जाए तो खेल के आनंद को चार गुना बढ़ा देते हैं. तो 'बल्लाबोल' के इस बेहद ख़ास एपिसोड में हमने आवाज़ दी दिग्गज कॉमेंटेटर विनीत गर्ग को. इस दौरान उन्होंने कॉमेंट्री के शुरुआती दिनों के बड़े मज़ेदार क़िस्से सुनाए. किसने उन्हें मौक़ा दिया, पहली ही कॉमेंट्री के लिए दिल्ली आने से पहले उनके हाथ-पांव क्यों फूल गए थे? उन दिनों अंपायरिंग में बेईमानी कैसे होती थी और अंपायरों के फैसले भारत के ख़िलाफ़ कैसे जाते थे? क्रिकेट में नए नए आए सचिन तेंदुलकर को लिफ़्ट में उन्होंने क्या सलाह दी, ब्रायन लारा ने मैदान पर दबंगई दिखाने की कोशिश क्यों की, इंडियन कोच जॉन राइट ने कैसे उनकी फिरकी ली थी, इमरान ख़ान विनीत गर्ग से ख़फ़ा क्यों हो गए थे, पाक़िस्तान में कम्युनिकेशन सिस्टम फ़ेल होने पर उन्होंने कैसे कॉमेंट्री की, उनके कॉमेंट्री करियर के बेस्ट मोमेंट्स कौन से हैं और भी बहुत कुछ सुनिए कुमार केशव के साथ. कुछ पूछना रह गया तो कमेंट बॉक्स में बताइये और इस वीडियो को ज़्यादा से ज़्यादा शेयर कीजिए. साउंड मिक्सिंग: रोहन भारती

„Protestuojanti kultūros bendruomenė Lietuvoje koreguoja vertybinį politikos turinį, netarnaudama politinėms jėgoms. Tačiau nepamirškime budrumo. Naivu būtų manyti, kad atvirą pilietinę akciją, kurioje labai daug jaunimo, nepanorėtų priglobti politinė jėga“, – sako rašytoja Dalia Staponkutė.Gargžduose pristatoma premjera  „Žmogus mėnulyje“.Eindhovene vyksta Nyderlandų dizaino savaitė – vienas svarbiausių ateities dizaino renginių Europoje, kasmet sutraukiantis šimtus tūkstančių lankytojų ir pristatantis ne tik objektus, bet ir idėjas apie tai, kaip galėtų atrodyti mūsų gyvenimas po 5, 20 ar net 50 metų.Ciklas skirtas Sarbievijaus ir baroko literatūros metams.Vilniuje buvo teikta pirmoji bendra YIVO žydų mokslinių tyrimų instituto ir Lietuvos nacionalinės Martyno Mažvydo bibliotekos premija. Apdovanojimas po mirties skirtas Antanui Ulpiui – žmogui, kuris sovietmečiu, tyliai ir rizikuodamas savo laisve, išsaugojo tūkstančius žydų knygų ir dokumentų nuo sunaikinimo.Ved. Justė Luščinskytė

MTV uždaro kanalus Europoje.Gargžduose pristatoma premjera „Žmogus mėnulyje". Mariaus Pinigio bei Andriaus Stakelės sukurtą šokio ir muzikos spektaklį pamatys penkių šalies miestų auditorijos.Lietuvos kultūros asamblėja kviečia jungtis į protesto mėnesį.Ciklas skirtas Sarbievijaus ir baroko literatūros metams.Ved. Donatas Šukeli

ThePrintAM: What has Singapore Police said on Zubeen Garg's death?

In this Maitri podcast episode, Chanchal Garg opens up about the spiritual and sexual abuse that shook her identity and forced her to confront a life shaped by duty and sacrifice. She courageously shares her journey of personal transformation—unearthing hidden truths that have been buried under cultural obligations, spiritual trauma, and the silence often expected of women.This moving conversation offers courage and hope for anyone navigating cultural pressures, intergenerational conflicts, or the weight of victim-blaming.Chanchal Garg is a speaker, author, executive coach, and conscious leadership facilitator. For over eight years, she has facilitated a course on interpersonal dynamics at Stanford University's Graduate School of Business. Chanchal is also the author of Unearthed: The Lies We Carry and the Truths They Bury.

What happens when your safe place becomes a battlefield for your beliefs, your body and your cultural identity?  In this truth-telling episode, author and Stamford University interpersonal dynamics educator Chanchal Gang shares her escape from spiritual and sexual abuse and what she did to reclaim her voice and set boundaries. Chanchal shares how she broke free from cultural and familial expectations and shifted to a life of healing with tools of transformation that include yoga, ancestral healing, and radical empathy. With raw honesty and fierce compassion, we explore the challenges women, especially women of color, face everyday. This powerful conversation is a survival guide for trauma recovery, boundary setting, cultural identity, and reclaiming your story.   GRAB CHANCHAL'S BOOK Unearthed: The Lies We Carry & The Truths They Bury https://amzn.to/47fDpZ6  (Amazon) REDEFINE LEADERSHIP QUIZ https://chanchalgarg.com/quiz/   RAISE YOUR VOICE AND UPGRADE YOUR MIC!  ⁣ Hilary is Using Shure MV7+ Mic  ⁣ https://amzn.to/3ZBaXNm (Amazon)⁣   ⁣As an Amazon Associate, I earn from qualifying purchases CONNECT WITH CHANCHAL https://chanchalgarg.com/   JOIN ME ON SUBSTACK - THE BRAIN CANDY BLUEPRINT! ⁣https://substack.com/@hilaryrusso ⁣ GET BRAIN CANDY & WAYS TO BE KIND TO YOUR MIND DELIVERED TO YOUR INBOX⁣ https://www.hilaryrusso.com/braincandy⁣ DISCOVER HAVENING TECHNIQUES TRAININGS & WORKSHOPS⁣ https://www.hilaryrusso.com/training⁣ ⁣ BOOK HILARY FOR YOUR NEXT EVENT OR ATTEND!⁣ https://www.hilaryrusso.com/events⁣ ⁣ CONNECT WITH HILARY⁣ https://www.linkedin.com/in/hilaryrusso⁣ https://www.instagram.com/hilaryrusso⁣ https://www.instagram.com/hilisticallyspeaking⁣ https://www.youtube.com/hilaryrusso⁣ https://www.hilaryrusso.com/podcast⁣ ⁣ MUSIC by Lipbone Redding⁣ https://www.lipbone.com⁣  

BJP receives a big blow in Bodoland Territorial Council polls but Gaurav Gogoi-led Congress has little to cheer, ThePrint Political Editor DK Singh elaborates in this episode of Politically Correct----more----Read full article here: https://theprint.in/opinion/politically-correct/bodoland-bjp-in-assam-zubeen-death-himanta/2753348/

Teatime with Miss Liz Presents: “Stories That Shape Us: From Reviewer to Author – The Journey of Ekta R. Garg” Introduction: Join me, Miss Liz, on September 30th at 3 PM EST, for an inspiring Teatime with Ekta R. Garg — a reviewer, editor, author, and dreamer of stories and books. Since 2005, Ekta has worked in niche publishing, covering a range of topics including healthcare, home improvement, and Hindi films. She shares her deep love of stories by judging writing contests, hosting writing workshops, and podcasting about books and the art of writing. Ekta is the award-winning author of the holiday novella “The Truth About Elves”, the fairy tale for grownups “In the Heart of the Linden Wood”, and her newest release “The Witch's Apprentice and Other Stories”, published by Atmosphere Press. Her passion for storytelling is matched only by her mission to help others connect with their voices and creativity. Tagline: “Every story has a heartbeat — discover yours with Ekta R. Garg.”Description: Ekta R. Garg brings over two decades of experience in publishing and storytelling to this Teatime conversation. From editing and reviewing to mentoring and writing, she believes that stories are our bridges to understanding and empathy. In this session, we'll delve into her journey as a multi-talented creative, her award-winning works, and her insights on how stories shape, heal, and guide us toward growth. If you've ever dreamed of writing your story or want to understand the power of storytelling better, you won't want to miss this episode. Closing: Join Miss Liz and Ekta for an enlightening conversation filled with heart, inspiration, and the magic of words. Mark your calendar — September 30th at 3:00 PM EST — and join a storytelling journey that promises to inspire writers, readers, and dreamers everywhere.

I feel blessed to have had the chance to converse with this week's inspirational guest, Chanchal Garg, speaker, executive coach, facilitator at The Stanford Graduate Business School, and author. Please join us as we discuss: her philosophies on healing ancestral trauma her insights on breaking cultural traditions what she means by "we are not of our body" and the concerns of ignoring the messages of our body choosing our language and embodiment and so much more! Welcome to The Healing Place Podcast! I am your host, Teri Wellbrock. You can listen in on Pandora, Apple Podcasts, Spotify, iHeartRadio, Deezer, Amazon Music, and more, or directly on my website at www.teriwellbrock.com/podcasts/. You can also catch our insightful interview on YouTube. Bio: Chanchal Garg Chanchal Garg is a speaker, author, executive coach, and conscious leadership facilitator. She transforms lives by helping clients break through limiting beliefs and create authentic connections. Drawing from her MBA and personal experiences, she addresses difficult truths directly while fostering environments of openness and collaboration. For over seven years, Chanchal has facilitated Stanford University's Graduate School of Business' most popular elective course on interpersonal dynamics, impacting over 500 future business leaders. As the founder of Real Space—a thriving six-figure coaching business—she guides leaders to transcend cultural and societal constraints, harnessing their personal power in both work and life. Chanchal is the author of Unearthed: The Lies We Carry and the Truths They Bury. Her expertise has been showcased through speaking engagements, including Lululemon's International Women's Day event, and on podcasts such as She Has the Mic and I Don't Give a Should. Websites: https://chanchalgarg.com/ Teri's #1 best-selling books and #1 new-release book can be found here. Teri's inspirational audiobook productions can be found here. Teri's monthly newsletter can be found here. Teri's book launch team can be found here. AMAZON AFFILIATE Teri Wellbrock and Unicorn Shadows are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. In other words, I make commission off of purchases made using any affiliate links on my site.

In this episode, we discuss the journey of Chanchal Garg and her route to reclaiming her life. In this searing memoir, Chanchal reveals the spiritual and sexual abuse that shattered her sense of self and forced her to question a life defined by duty and sacrifice. Unearthed is a powerful call to every woman who has ever felt silenced-an invitation to trust your inner voice, reclaim your story, and return to yourself. Silence can be very powerful, but it can also address identity in this episode, rself to heal. I allow you to be a hindrance, trauma, fear, and the journey of reclaiming power in your own life.https://chanchalgarg.com/

Are the Garg kids really nepo babies...or is the bigger question whether my husband is a nepo husband? In this week's episode, we unpack what nepotism means to us, how it's shaped our success, and how the kids are perceived for working in the family business. Thank you to our sponsor College Shortcuts! We are excited that Neha is offering a free information call to the first 100 families who schedule a call at their website at www.collegeshortcuts.com to learn about the latest trends in collegeadmissions! They have limited spots, so do it today. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Savaitinėje 15min laidoje „Skrieja kamuolys“ apžvelgiamos Lietuvos ir užsienio futbolo aktualijos. Šią savaitę aptariamos Lietuvos futbolo A lygos ir LFF taurės peripetijos, Čempionų lygos startas bei tradiciškai aptariami stipriausių Europos šalių lygų reikalai. Komanda – 15min žurnalistai Marius Bagdonas ir Aurimas Tamulionis bei „Go3” komentatorius Karolis Dudėnas. 00:00 Intro 00:18 Šiuolaikinės tendencijos, Marijampolė ir kiti įžangos dalykai 06:30 Lietuvos teisėjų ir „Panevėžio“ atstovų sunkiai nuplaunama gėda 18:00 „Hegelmann“ išsigelbėjimas Telšiuose 24:53 LFF taurės būsimo finalo repeticija: „Panevėžys“ - „Hegelmann“ 28:45 Elygos šou Alytuje 34:07 Šviesa tunelio gale: „Žalgiris“ pas „Riterius“ 42:56 „Sūduvos“ sunki pergalė Gargžduose 50:40 „Kauno Žalgiris“, vaikiška klaida ir kovingi Telšiai 1:02:16 Lietuviški darbai Europos stadionuose 1:05:12 Čempionų lygą atidarė Donatas Rumšas ir kompanija 1:07:40 Čempionų lygos pirmasis turas ir genijus Mourinho 1:24:01 Liverpulio derbis 1:25:35 „Manchester United“ pergalė prieš „Chelsea“ 1:33:04 „Arsenal“ ir „Manchester City“ akistata 1:53:04 „La Liga“ 2:03:24 „Bundesliga“ 2:09:20 „Serie A“ 2:14:20 „Ligue 1” ir „Eredivisie“

pWotD Episode 3062: Zubeen Garg Welcome to popular Wiki of the Day, spotlighting Wikipedia's most visited pages, giving you a peek into what the world is curious about today.With 338,849 views on Friday, 19 September 2025 our article of the day is Zubeen Garg.Zubeen Garg (born Zubeen Borthakur (Assamese pronunciation: [zubin bɔɹtʰakuɹ]; 18 November 1972 – 19 September 2025) was an Indian musician who primarily worked and sang in the Assamese, Bengali, and Hindi-language film and music industries. He had also sung in 40 other languages and dialects, including Bishnupriya Manipuri, Adi, Boro, English, Goalpariya, Kannada, Karbi, Malayalam, Marathi, Mising, Nepali, Odia, Sanskrit, Sindhi, Tamil, Telugu, and Tiwa. Garg was a multi-instrumentalist and played 12 instruments including anandalahari, dhol, dotara, drums, guitar, harmonica, harmonium, mandolin, keyboard, tabla, and various percussion instruments. He was regarded as one of the most influential musician in Assam, and was also the highest-paid singer.This recording reflects the Wikipedia text as of 01:53 UTC on Saturday, 20 September 2025.For the full current version of the article, see Zubeen Garg on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm neural Ruth.

00:00 – D-Mo potenciali stotelė 05:08 – ačiū skaitytojams 08:35 – pakilimas FIBA reitinge 12:12 – T.Pačėso pasisakymai 18:09 – „Kibirkštis“ priartėjo prie Eurolygos 22:17 – LKL spaudos konferencija ir KMT 28:30 – „Žalgirio“ privalumai ir trūkumai 42:50 – „Ryto“ žaidimas 47:31 – įdomesnis nei pernai „Lietkabelis“ 52:48 – abejones keliantis „Neptūno“ legionierius 59:55 – įdomūs „Juventus“ lietuviai 1:03:40 – „Šiaulių“ trūkumai ir C.Reddishas 1:11:50 – „Jovana“ ir „Reddit“ 1:14:40 – „Gargždai“ ir „Nevėžis“ 1:21:35 – spėjimai

With all eyes on the Fed's FOMC decision, Vishal Garg breaks down the current state of the housing market and what to expect from potential rate cuts. Garg notes that while inventory is up and consumers are stepping back, rates have already fallen in anticipation of a cut, which could bring relief to the market. Garg also discusses how AI is revolutionizing the mortgage process, making it faster and cheaper for lenders to pass on savings to consumers.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

LKL prezidentas Remigijus Milašius šiandien pristatė naująjį Lietuvos krepšinio lygos sezoną, kuris prasidės jau šį šeštadienį.

Norėdami matyti visą podkastą spauskite čia: https://contribee.com/krepsinisnet 00:00 – iš lėktuvo – į podkastą 01:10 – įspūdingas finalas 19:24 – D.Sabonis rinktinėje gali tapti A.Šengunu? 29:15 – vos bronzos nepavogę suomiai 46:40 – „Juventus“ laukianti atranka Rėmėjų dalyje aptartos šios temos: 52:12 – komedija su LKL pavadinimu 55:22 – geriau nei tikėjomės – „Gargždai“ 1:01:40 – ką gali „Nevėžis“? 1:08:00 – be centrų ir su traumomis 1:15:00 – C.Reddisho reikalavimai „Šiauliams“ 1:24:05 – intriguojantys „Juventus“ lietuviai 1:28:23 – „Nevėžio“ žaidimas „Neptūne“ 1:33:22 – traumos ir kodėl išvyko F.Aimaqas 1:38:04 – „Ryto“ pasirengimas ir S.Lukošius 1:40:38 – pirmi įspūdžiai apie „Žalgirio“ žaidimą  

Send us a textThe Journeymen are back, diving straight into the late “penalty” in Vancouver, the winners and losers of the Secondary Transfer Window, and the League's Cup Semifinals.Video Chapters:0:00 - Intro & Garg's is officially out of the dumpster1:00 - Phantom PK Call in Vancouver?3:01 - Did the ref just have a bad game?6:17 - The one thing all players want from refs9:51 - Is St. Louis in a full rebuild?12:29 - How to lose a fanbase 10117:06 - Secondary Transfer Window: Winners and Losers  32:22 - Checking in on the Journeymen's Supporter's Shield and MLS Cup Predictions34:30 - League's Cup Semifinals 46:24 - What's going on with the Galaxy?

Listen with Irfan (LwI)A tapestry of voices and stories, spun with careSupport LwI — a soulful creation shaped by affection, thriving on the warmth of its listeners. Your contribution helps keep this free, bringing global stories, rare sound recordings, and personal music archives to all without paywalls. I curate voices, readings from literature, and cultural studies with immense care.Through my recent initiative, Read Aloud Collective, voices from around the world are coming together in celebration of spoken word.Grateful for your love -keep listening, keep supporting!  Bank Name: State Bank Of IndiaName: SYED MOHD IRFANAccount No:32188719331Branch: State Bank of India, Vaishali Sec 4, GhaziabadIFSC–SBIN0013238UPI/Gpay ID irfan.rstv-2@oksbiSupport LwI by contributing:  https://rzp.io/rzp/MemorywalaPayPal ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠paypal.me/farah121116⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Your comments and feedback are welcome. Write to ramrotiaaloo@gmail.com

15min laidoje „Skrieja kamuolys“ apžvelgiamos Lietuvos ir užsienio futbolo aktualijos. Šią savaitę kalbama apie Vilniaus „Žalgirio“ vadovės Vilmos Venslovaitienės manevrus perleidžiant sau, o vėliau ir parduodant klubo dalis, aptariamas „Kauno Žalgirio“ pasirodymas UEFA Konferencijų lygos trečiajame atrankos etape bei tradiciškai apžvelgiamos A lygos ir LFF taurės kovos. Laidoje dalyvauja – 15min žurnalistas Marius Bagdonas ir „Go3“ komentatorius Karolis Dudėnas. 00:00 Intro 00:18 Vilniaus „Žalgiris“, Vilma ir akcijos 36:05 „Kauno Žalgirio“ žygis Europoje ir nelaimė 49:30 Lietuvių pasirodymai Europoje 51:00 „Žalgirio“ neįkvepianti pergalė ir lagaminai 55:32 Pelnyta „Džiugo“ pergalė Panevėžyje 58:40 Alytiškių sensacija Raudondvaryje 1:03:35 „Riterių“ krizę pagilinę Gargždai 1:05:33 LFF taurė ir „Hegelmann“ bei „Sūduvos“ žingsniai pirmyn 1:11:32 „Bendruomenės skydas“ 1:20:29 Anglijos „Premier“ lygos sezono prognozės 1:29:05 Ispanijos „La Liga“ sezono prognozės

Today on Crime & Entertainment we have, Ankur Garg. Ankur is the CEO of AKG Creative and former co-founder of Shredz supplement brand.  Ankur helped build Shredz to nine-figures in profits prior to his departure. Ankur left millions on the table after his partners had a loophole in the contract that came back to bite him.  Yet during his tenure he was influential in the creation of what is now known as “influencer marketing.”  He is widely considered the OG of Influencer Marketing. He now owns a beautiful podcasting studio in New Jersey, which is where this was filmed at. Check out all his socials below. Check out Ankur herehttps://www.instagram.com/ankurkgarg?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==https://www.instagram.com/flexworkstudios?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==Links to Crime & Entertainment Like us on Facebook -    / crimeandentertainment  Follow us on -   / crimenentertainment  Listen on Spotify - https://open.spotify.com/show/4T67Bs5... Listen on Apple Music - https://podcasts.apple.com/us/podcast... Listen on Stitcher - https://www.stitcher.com/show/crime-e... Listen on Google Podcast - https://podcasts.google.com/feed/aHR0... Listen on Amazon Music - https://music.amazon.com/podcasts/9cd...

Mitch holes up in a private gym for two weeks with his newly acquired sidekick slash personal trainer Andy Richter to transform himself into a muscle-bound caped detective.Endnotes:Louie Anderson, Hi Mom: Stories for My Mother, But You Can Read Them Too (Touchstone Books, New York, 2018) p. ; Capsule Summary: Continuing the Hi Dad formula, a series of letters to the deceased matriarch of the Anderson clan. Thankfully, less traumatized and more jovial than the earlier book, but still weighted down by the plodding conceit. Most interesting aspect is the creation of Christine Baskets as a tribute to his mom and a poignant third (fourth? fifth?) act in a long and varied career. Side note: the hardest I have ever laughed was watching Louie Anderson live at the Paramount Theatre in 1991 with my father. He did a bit about stubbing his toe that had both of us gasping for air and literally falling out of our seats. Cara and I also saw him deliver the JFL keynote address in 2019 afterwhich he posed for selfies with us and was very comforting regarding our recently deceased cat Carl. His books are more therapeutic than hilarious, but he'll always have a very warm place in my heart. Slack Score: 2; Snark Score: 7; Overall FCA ranking: 176Zarna Garg, This American Woman; A One-in-a-Billiion Memoir (Ballantine, New York, 2025) p.227; Capsule Summary: A comedian origin story very much unlike any other. Garg didn't grow up dreaming of being Joan Rivers or anything like that, in fact, she seems to have barely understood that stand up comedy existed before her daughter essentially dared her into it, following a string of entrepreneurial failures. Hers is a story of brutal impoverishment and hardship as a homeless youth on the streets of Mumbai and extraordinary wealth and privelege at various other times of her life. Like her hero and champion Kevin Hart, she is unabashedly ambitious and driven by financial rapacity. I don't love that, and her prolonged tales of frustration with her children's $100,000/year elementary school education were not something I  found very relateable/easily identified with. Nevertheless, she is a talented writer and a funny human, and occupies a unique cultural perspective in the world of stand up, which is invaluable and her daughter apparently truly cares for her more than any teenager has ever cared for a parent, so that says everything you need to know about her value as a human. Slack Score: -7; Snark Score: 9; Overall FCA ranking: 115Trrevor Noah, Born a Crime: Stories From a South African Childhood (One World, New York, 2016) p. 43; Capsule Summary: Regardless of your opinion of Noah as a stand up or Daily Show host (pretty mid on both fronts as far as I'm concerned) there's no question that this is a top tier FCB. Noah's story of growing up in South Africa semi-secretly (see the title) is riveting, wryly engaging, and tremendously moving, especially the last chapter on his mother. ; Slack Score: -9; Snark Score: 12; Overall FCA ranking: 8unstoppablefarce.com #comedy #standup #speculativefiction #speculativememoir #neilhamburger #longmontpotioncastle #elephantgraveyard #edinburgh #onemanshow

We're revealing our wild nightlife. But spoiler, it involves melatonin, and no martinis. This episode hones in on how the Garg's party over generations, our nightlife experience, and our take on alcohol. Should it be shameful to partake in or avoid alcohol? And thank you The RealReal for sponsoring this episode. The RealReal is the world's largest and most trusted resource for authenticated luxury resale. With thousands of new arrivals daily, no one does resale like The RealReal. Get $25 off your first purchase when you go to TheRealReal.com/zarna. Visit curiouscardinals.com/zarna and if you sign up for a 2 month subscription by September 1st, get $100 off.” Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit “Sam” Garg, MD and Jean-Pierre Hubschman, MD. Welcome to the Eyeluminaries podcast 00:05 Review of episode 33 00:49 Intro of Tibor Juhasz, PhD 01:35 Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27 How is ViaLase impacting glaucoma treatment? 06:55 How the treatment works 08:24 The importance of having a good team 11:02 Intro of Richard L. Lindstrom, MD 12:58 What is your perspective on what is happening today and what changes are you hoping for? 14:28 Integrated eye care delivery 17:00 Dentistry, a future model for eye care 17:50 Post-graduate medical education is changing 19:09 Was there a technology that you thought was a slam dunk and failed? 23:01 Any technology that you didn't expect to take off? 24:37 Intro of Sumit “Sam” Garg, MD 26:58 What do you see changing in ophthalmology residency programs around the country? 28:52 How do you instruct young physicians to be collaborative in care? 30:42 If you weren't a cornea specialist (or a model) what would you be? 32:10 Advice for young ophthalmologists today? 33:42 Share a Jim Mazzo story with us! 35:28 Intro of Jean-Pierre Hubschman, MD 37:07 Why did you, with a robotics company, decide to start in cataract surgery? 38:23 How do you become more efficient in robotic surgery? 41:00 How do we work on the economic side of this? 43:38 What's it like running a company vs being a retina surgeon? 44:46 Give us your feedback 48:16 Thanks for listening 48:30   Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS. Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News. Sumit “Sam” Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine. Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.   We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

Tomas Purlys, Karolis Tiškevičius ir Jonas Miklovas sugrįžo aptarti ryškiausias krepšinio aktualijas. Nuo įspūdingo „Žalgirio” ir jo dalininkų pirkinių iki nutrūkusių Valančiūno ir „Panathinaikos” vestuvių. Tinklalaidės partneriai: –Nord VPN. Apsilankykite https://nordvpn.com/basketnews ir dvejų metų planui gaukite keturis papildomus mėnesius. Jei nepatiks - per 30 dienų galite atgauti pinigus. – Visą liepos mėnesį visi SPORT linijos maisto papildai 2 už 1 kainą. Apsilankyk ir išsirink: https://www.biofarmacija.eu/sport-linija – Nealkoholinis alus „Gubernija”, daugiau informacijos – https://gubernija.lt/ – Komandinis „Vienas prieš vieną“ protmūšis – jau liepos 30 d. BasketNews vasaros namai Bernardinų kieme. Suburk komandą ir išbandyk savo jėgas! Registracija ir renginio informacija: https://fb.me/e/6zoEoING5 Temos: Grįžtam - prisikaupė reikalų (0:00); Kaip „Žalgirio” dalininkai Vilniaus turtą perka (2:53) Tubelio atsiprašymas ir potencialas „Žalgiryje” (15:55); „Ryto” laimėjimai – išsaugotas Radzevičius ir Gudaitis (24:43); Solidūs „Ryto” papildymai trenerių štabe (27:10); Stambūs pokyčiai „Žalgirio” trenerių štabe (29:10); Gudrus Eurolygos tvarkaraštis, vasaros turgus (40:41); Kiekvieną poziciją sustiprinęs „Žalgiris” (45:04); Rinktinės tvarkaraštis ir „Lietkabelio” kova su „Lions” (48:38); Padidėjęs Buzelis ir U20 rinktinės sėkmė (50:45); Basketnews vasaros namai (59:50); Ar sąžiningas „Gargždų” sugrįžimas į LKL? (1:01:00); Neįvykęs JV ir PAO vestuves nutraukęs „Nuggets” (1:05:53).

Garg the Good ep.785 Dominic Bowers-Mason would like to keep his information private, but he hopes you enjoyed the story! Listen to the original release here: https://www.youtube.com/watch?v=0_JWHpMKF4w&t=94s&ab_channel=TallTaleTV   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords  

There is research to show that climate washing is on the uptick along with a growing trend by companies worldwide to utilise carbon credits to offset greenhouse gas emissions. The trend (carbon offsetting) is driven largely by companies making net-zero pledges. However in the absence of standardised frameworks and regulations claims of greenwashing can undermine the credibility of carbon mitigation efforts examples: overstating the impact, under reporting harm to communities or environmentTo understand the ecosystem better I spoke with Shreya Garg, a seasoned climate professional and auditor to share her expertise on the dynamics of the carbon markets. Independent auditors are key to building trust in carbon markets by provide objective assessment of projects, prevent misrepresentation of data. In our wide-ranging conversation we spoke about additionality, permeance, community impact…...

Are the Garg parents sexist? This week, we expose the double standards in how parents treat sons vs. daughters, as well as dig into the juicier truth of whether we're just repeating the same madness us parents were raised with. Thank you to our #sponsor Spicewell - get Spicewell NOW at spicewell.com make sure to use code ZARNA15 to get 15% off at: http://spicewell.com and code ZARNA15. Apple: https://podcasts.apple.com/us/podcast/the-zarna-garg-show/id1699849965 Spotify: https://podcasters.spotify.com/pod/show/zarna-garg BOOK YOUR TICKET TODAY! Website: https://zarnagarg.com/ Instagram : @ZarnaGarg Podcast : @zarnagargfamilypodcast #podcast #family #indian #comedy #newyorkcity #culture #asia #usa #healthy #parenting Learn more about your ad choices. Visit podcastchoices.com/adchoices

Summer at the Gargs is off to a not so great start. We're already ruining each other's plans and curating movie lists no one agrees on. Summer for the Garg's is not all glitz and glamour, and it likely isn't for you either. Tune in and find out.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Let's be honest—most founders are chasing traction without stopping to ask: Is this still what I want to build?In this episode, I talk with Amit Garg, Managing Partner at Tau Ventures, about what it means to build a purpose-aligned business from the ground up. From launching a hospital in India to raising $86M for a venture fund, Amit shares what real alignment looks like.

We say that you tend to follow the religious practices you're born into — but what if every Garg in the house had a different take on their religion? In this episode, we ask every Garg what or who they believe in, to what extent religion plays a role in their lives, and how it's like developing your own religious values beyond what you were raised with. Learn more about your ad choices. Visit megaphone.fm/adchoices